Cargando…
CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management
SIMPLE SUMMARY: The inv(16)/t(16;16) AML is a disease that is considered relatively easy and straightforward to be diagnosed in the clinical laboratories. Up to date, CBFB FISH and/or CBFB-MYH11 RT-PCR are still the major diagnostic assays utilized in the clinical laboratories. However, incidental C...
Autores principales: | Yang, Richard K., Toruner, Gokce A., Wang, Wei, Fang, Hong, Issa, Ghayas C., Wang, Lulu, Quesada, Andrés E., Thakral, Beenu, Patel, Keyur P., Peng, Guang, Liu, Shujuan, Yin, C. Cameron, Borthakur, Gautam, Tang, Zhenya, Wang, Sa A., Miranda, Roberto N., Khoury, Joseph D., Medeiros, L. Jeffrey, Tang, Guilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582369/ https://www.ncbi.nlm.nih.gov/pubmed/34771519 http://dx.doi.org/10.3390/cancers13215354 |
Ejemplares similares
-
PPP1R7 Is a Novel Translocation Partner of CBFB via t(2;16)(q37;q22) in Acute Myeloid Leukemia
por: Wang, Lulu, et al.
Publicado: (2022) -
Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series
por: Alotaibi, Ahmad S., et al.
Publicado: (2020) -
3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features
por: Tang, Zhenya, et al.
Publicado: (2023) -
KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma
por: Saglam, Ozlen, et al.
Publicado: (2020) -
MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome
por: Yin, Wei, et al.
Publicado: (2022)